Tom Sorahan1. 1. Institute of Occupational and Environmental Medicine, University of Birmingham, Edgbaston, Birmingham B15 2TT, UK. t.m.Sorahan@bham.ac.uk
Abstract
BACKGROUND: There is evidence that arsenic is a late-stage human lung carcinogen. AIMS: To investigate lung cancer risks in a cohort of cadmium recovery workers in relation to period from ceasing exposure to arsenic. METHODS: The mortality experience (1940-2001) of a cohort of 625 male workers from a US cadmium recovery plant was compared with expectations based on US national mortality rates. RESULTS: There was a statistically significant (P < 0.05) negative trend in lung cancer standardized mortality ratios in relation to period from ceasing arsenic exposure. CONCLUSIONS: The findings are consistent with the hypothesis that arsenic is a late-stage human carcinogen.
BACKGROUND: There is evidence that arsenic is a late-stage human lung carcinogen. AIMS: To investigate lung cancer risks in a cohort of cadmium recovery workers in relation to period from ceasing exposure to arsenic. METHODS: The mortality experience (1940-2001) of a cohort of 625 male workers from a US cadmium recovery plant was compared with expectations based on US national mortality rates. RESULTS: There was a statistically significant (P < 0.05) negative trend in lung cancer standardized mortality ratios in relation to period from ceasing arsenic exposure. CONCLUSIONS: The findings are consistent with the hypothesis that arsenic is a late-stage human carcinogen.
Authors: Robert M Park; Leslie T Stayner; Martin R Petersen; Melissa Finley-Couch; Richard Hornung; Carol Rice Journal: Occup Environ Med Date: 2012-01-22 Impact factor: 4.402
Authors: Cheng Chen; Pengcheng Xun; Cari Tsinovoi; Leslie A McClure; John Brockman; Leslie MacDonald; Mary Cushman; Jianwen Cai; Lisa Kamendulis; Jason Mackey; Ka He Journal: Neurology Date: 2018-06-22 Impact factor: 9.910